Gly-Sal 5-2
- Product NDC
- 51326-927
- 11-digit product format
- 513260927
- Labeler code
- 51326
- Product ID
- 51326-927_b72df2c6-2e93-4daf-8bf9-057b17f31bbc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Salicylic Acid
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- Topiderm, Inc.
- Application
- M006
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-07-30
- Substance
- SALICYLIC ACID
- Active strength
- 20 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gly-Sal 5-2
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SALICYLIC ACID | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O414PZ4LPZ |
| Rxcui | 562600 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51326-927-01 | Gly-Sal 5-2 | 200 mL in 1 BOTTLE, PLASTIC | LIQUID | 200 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51326-927 | GLY-SAL 5-2 (SALICYLIC ACID) LIQUID [TOPIDERM, INC.] | 1 | Current NDC, 1 package rows | 20240808_a75e4cee-678f-4e44-9e5e-bafae1c23f9b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51326-927-01 | 51326092701 | 200 mL in 1 BOTTLE, PLASTIC (51326-927-01) | 200 ml | 2020-07-30 | No | No | Historical |